Provided by Tiger Fintech (Singapore) Pte. Ltd.

Taysha Gene Therapies, Inc.

2.10
+0.200010.53%
Post-market: 2.140.0400+1.90%19:55 EDT
Volume:6.34M
Turnover:13.47M
Market Cap:430.61M
PE:-5.88
High:2.28
Open:1.86
Low:1.85
Close:1.90
Loading ...

Taysha Gene Therapies announces inducement grant under Nasdaq listing rule

TIPRANKS
·
03 Jan

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
03 Jan

Press Release: Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Dow Jones
·
03 Jan

Taysha Gene Therapies files $300M mixed securities shelf

TIPRANKS
·
14 Dec 2024

Taysha Gene Therapies announces inducement grant under Nasdaq listing rule

TIPRANKS
·
06 Dec 2024

BRIEF-Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Reuters
·
06 Dec 2024

Buy Rating for Taysha Gene Therapies Due to Safer Administration Method and Lower Viral Dose

TIPRANKS
·
22 Nov 2024

Taysha Gene Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
15 Nov 2024

Taysha Gene Therapies price target raised to $8 from $6 at Canaccord

TIPRANKS
·
15 Nov 2024

Q3 2024 Taysha Gene Therapies Inc Earnings Call

Thomson Reuters StreetEvents
·
15 Nov 2024

Taysha Gene Therapies Price Target Maintained With a $7.00/Share by Cantor Fitzgerald

Dow Jones
·
14 Nov 2024

Taysha Gene Therapies Inc (TSHA) Q3 2024 Earnings Call Highlights: Clinical Progress and ...

GuruFocus.com
·
14 Nov 2024

Taysha Gene Therapies: Promising Developments and Strong Financial Position Support Buy Rating

TIPRANKS
·
14 Nov 2024

Taysha Gene Therapies Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
14 Nov 2024

Taysha Gene Therapies, Inc. (TSHA) Reports Q3 Loss, Lags Revenue Estimates

Zacks
·
14 Nov 2024

Taysha Gene Therapies Q3 2024 GAAP EPS $(0.10) Misses $(0.09) Estimate, Sales $1.788M Beat $1.648M Estimate

Benzinga
·
14 Nov 2024

Dow Dips Over 200 Points; Home Depot Posts Upbeat Earnings

Benzinga
·
13 Nov 2024

Taysha Gene Therapies Up Nearly 39%, on Pace for Largest Percent Increase Since August 2023 -- Data Talk

Dow Jones
·
13 Nov 2024

Cantor Fitzgerald Reaffirms Their Buy Rating on Taysha Gene Therapies (TSHA)

TIPRANKS
·
12 Nov 2024

Buy Rating Affirmed for Taysha Gene Therapies Amid Promising TSHA-102 Trial Results

TIPRANKS
·
12 Nov 2024